Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Coeptis Therapeutics Holdings (COEP) over the last 3 years, with Q3 2025 value amounting to $2.1 million.

  • Coeptis Therapeutics Holdings' Receivables - Other changed N/A to $2.1 million in Q3 2025 from the same period last year, while for Mar 2024 it was $108581.0, marking a year-over-year change of. This contributed to the annual value of $38978.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Receivables - Other of $2.1 million as of Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Receivables - Other peaked at $2.1 million during Q3 2025, and registered a low of $833.0 during Q3 2023.
  • In the last 3 years, Coeptis Therapeutics Holdings' Receivables - Other had a median value of $73779.5 in 2023 and averaged $562190.0.